Concord Medical Services ADRs Climb After Chinese Hospital Unit Gets New License
Concord Medical Services' stock surged 11% to $5.61 after its subsidiary received a major medical equipment license in China. The company, focused on cancer care and research, will soon offer proton therapy treatment at Guangzhou Concord Cancer Center.